Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)

Clinical trial NCT04843774 · COMPLETED

Trial details

NCT number: NCT04843774
Sponsor: NYU Langone Health
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2021-04-20
Primary completion: 2023-04-18
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.